BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Pharmaceuticals\, medical device and life science organization
 s of all sizes have executed digital initiatives at a greater scale in 20
 20\, and continuing through 2021. Marketers do a good job showing how cha
 nnels reach customers with leading KPIs\, but how good a job are we doing
  demonstrating and actually measuring the impact of digital initiatives o
 n business\, especially across channels?\n\nThere are many KPIs and chann
 els that can be utilized. However\, if senior leadership is not asking th
 e right questions - it becomes increasingly difficult to understand where
  to make investments or deliver commercial transformation to actually del
 iver and measure ROI.\n\nToday\, there are more questions than answers:Wh
 at are the shortfalls\, and are there more strategic analytical roadmaps 
 for success as an industry?Is omnichannel driving business impact in a mo
 re virtual environment? Does it vary across therapeutic areas and special
 ties?How can we measure/track success as the channel mix changes over tim
 e as part of a more advanced attribution model?Does 'digital' need to be 
 de-siloed and experts redistributed across commercial functions?Ultimatel
 y\, how can the industry look to weather change in digital in this time o
 f flux?Following the resounding success of the inaugural Re:Imagine Pharm
 a Marketing - at the 2nd Re:Imagine Pharma Marketing\, this unique event 
 will provide a detailed view on these crucial supporting elements surroun
 ding launching new digital programs to ensure adoption and excellence in 
 execution from all stakeholders at your organization. Through case studie
 s and planning strategy\, you will leave this groundbreaking virtual even
 t with a more holistic internal view of driving innovation that can be ap
 plied to any new digital initiative.\n\nREASONS TO ATTEND- Amplify digita
 l at a critical time - identifying what the triggers for 'must do' change
 s\, and assessing if these are these connected to true long lasting digit
 al transformation.- Examining COVID forced acceptance of Omnichannel mark
 eting importance: where do CX and MCM groups need to channel their energy
  and what elements to prioritize to deliver a consistent experience of yo
 ur brand.- Analyze content consumption habits and behaviors of HCPs to de
 velop your content and engagement strategy.&nbsp\;- Scaling video content
  - keeping the authenticity\; examples of good stories that make for grea
 t content and pull the story forward to capture emotion.- Quantify the ri
 ght multichannel mix to select the right channel for the corresponding ca
 mpaing.- Optimize your patient journey and adherence as a marketing aid -
  how 'how to' and 'why' build as patients continue to increase levels of 
 expectation on access and reach.- Build a successful performance measurem
 ent framework to better interpret your data and understand your goals wit
 hin analytics.- Minimize data noise and digital health errors through sma
 rt use of data analytics and combining data sources.- Reimbursement: relo
 cating reimbursement as part of the innovation process - understand the v
 alue proposition of tech and quantify the willingness to pay.- Evaluate i
 f we have seen the promise of AI come to fruition in this current period 
 of turbulence. Has it done the job that we thought it would?.- Develop a 
 methodology of how to split personal and non-personal promotion.\n
DTEND:20210520T160000
DTSTAMP:20260512T234324Z
DTSTART:20210518T090000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:Pharmaceuticals\, medical device and life science organizations of
  all sizes have executed digital initiatives at a greater scale in 2020\,
  and conti...
UID:5b8250c3-a792-4c80-86bb-f14105456afa
END:VEVENT
END:VCALENDAR